Safety of 6 Hours Feeding After Extracorporeal Shock Wave Lithotripsy of Pancreatic Stone
SHEEL
1 other identifier
interventional
216
1 country
1
Brief Summary
The purpose of this study is to evaluate the safety of eating 6 hours after Extracorporeal Shock Wave Lithotripsy (ESWL). At present, ESWL and Endoscopic Retrograde Cholangiopancreatography (ERCP) are the routine ways to treat pancreatic duct stones. For large stones (diameter \> 5mm) , ESWL often needs to be performed many times. In clinical practice, fasting for 24 hours after surgery is often used, but long-term fasting brings strong discomfort to patients. However, the consensus for initiation timing of oral nutrition has not yet been established after ESWL. Thus, we design this trial to evaluate the safety of early feeding based on 6 hours parameter instead of the consensus definition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2022
CompletedFirst Posted
Study publicly available on registry
January 3, 2023
CompletedStudy Start
First participant enrolled
May 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2024
CompletedMarch 28, 2025
March 1, 2025
11 months
December 20, 2022
March 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
the incidence of post-ESWL pancreatitis
A diagnosis of post-ESWL pancreatitis was thus made if two of three of the following criteria were met, in accordance with the revised Atlanta international consensus: pain consistent with pancreatitis; amylase or lipase of at least three times the upper normal limit within 24 h of the procedure; or characteristic findings on imaging.
within 24 hours after ESWL
Secondary Outcomes (5)
the severity of post-ESWL pancreatitis
within 24 hours after ESWL
the incidence of other post-ESWL complications
within 24 hours after ESWL
the transient adverse events
within 24 hours after ESWL
abdominal pain relief rate
within 24 hours after ESWL
hunger relief rate
within 24 hours after ESWL
Study Arms (2)
Early feeding group
EXPERIMENTALPatients in the early diet group started oral intake 6 hours after ESWL of the day of procedure with a soft diet comprised 200 mL with 170 kilocalories. Observe closely until 24h, and then continue to fasting until the next ESWL/ERCP or change the diet to the general diet according to the actual clinical needs.
Standard fasting group
ACTIVE COMPARATORPatients in the standard fasting group were fasted for 24 hours after the first ESWL operation, and close observation during this fasting period. After 24 hours, according to the actual clinical needs, continue to fast until the next ESWL/ERCP operation, or change the diet to a general diet.
Interventions
Patients in the early diet group started oral intake 6 hours after ESWL of the day of procedure with a soft diet comprised 200 mL with 170 kilocalories.
Patients in the standard fasting group were fasted for 24 hours after the first ESWL operation, and close observation during this fasting period.
Eligibility Criteria
You may qualify if:
- Patients with chronic pancreatitis who completed ESWL.
You may not qualify if:
- Readmitted to the hospital during enrollment of the study;
- Cannot eat or rely on jejunal nutrition tube to give total parenteral nutrition for various reasons;
- With acute pancreatitis, perforation, infection, bleeding, steinstrasse and other complications and other serious clinical adverse events within 6 hours after ESWL;
- Suspected or confirmed malignancy
- Pancreatic ascites;
- Coagulation dysfunction;
- Taking chemotherapy drugs and immunosuppressants for a long time;
- Acute pancreatitis exacerbation or acute exacerbation of chronic pancreatitis (including biliary pancreatitis);
- Pregnant or breastfeeding women;
- Patients who refused to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Changhai Hospitallead
- Ruijin Hospitalcollaborator
- Shanghai Pudong New Area Gongli Hospitalcollaborator
- First People's Hospital of Hangzhoucollaborator
- LanZhou Universitycollaborator
- The Second Affiliated Hospital of Baotou Medical Collegecollaborator
Study Sites (1)
Changhai Hospital
Shanghai, 200433, China
Related Publications (1)
Hao L, Liu Y, Xie T, Wang T, Guo HL, Pan J, Wang D, Bi YW, Ji JT, Xin L, Du TT, Lin JH, Zhang D, Zeng XP, Zou WB, Chen H, Li BR, Liao Z, Cong ZJ, Shi RH, Li ZS, Hu LH. Risk Factors and Nomogram for Pancreatic Stone Formation in Chronic Pancreatitis over a Long-Term Course: A Cohort of 2,153 Patients. Digestion. 2020;101(4):473-483. doi: 10.1159/000500941. Epub 2019 Jun 25.
PMID: 31238312BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liang-hao Hu, MD
Changhai Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 20, 2022
First Posted
January 3, 2023
Study Start
May 29, 2023
Primary Completion
April 17, 2024
Study Completion
April 22, 2024
Last Updated
March 28, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share